Patent Assignment
Reel/Frame 014521/0959
Assignment of Assignor's Interest
Recorded: 2004-04-15
Pages: 5
Assignor
CALYDON, INC.
Executed: 2004-04-08
Assignee
CELL GENESYS, INC.
500 FORBES BOULEVARD, SSF, CALIFORNIA, 94080
Covered Properties
(17)
Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof
Application:
09/593,308 →
Adenovirus Vectors Specific for Cells Expressing Alpha Fetoprotein and Methods of Use Thereof
Application:
60/039,597 →
Adenovirus Vectors Specific for Cell Expressing a Mucin Gene and Methods of Use Thereof
Application:
60/039,599 →
Adenovirus Vectors Specific for Cells Expressing Androgen Receptor and Methods of Use Thereof
Application:
60/039,762 →
Adenovirus Vectors Specific for Cells Expressing Carcinoembryonic Antigen and Methods of Use Thereof
Application:
60/039,763 →
Novel Transgenic Plants
Application:
60/054,528 →
Human Glandular Kallikrein Enhancer, Vectors Comprising the Enhancer and Methods of Use Thereof
Application:
60/076,545 →
Adenovirus Vectors Containing Cell Status-Specific Response Elements and Methods of Use Thereof
Application:
60/099,791 →
Methods of Enhancing Effectiveness of Therapeutic Viral Immunogenic Agent Administration
Application:
60/103,445 →
Target Cell-Specific Adenoviral Vectors Containing E3 and Methods of Use Thereof
Application:
60/114,262 →
Human urothelial cell specific uroplakin transcriptional regulatory sequences, vectors comprising a uroplakin-specific transcriptional regulatory sequences, and methods of use thereof
Application:
60/191,861 →
Methods of Treating Neoplasia with Combinations of Target Cell-Specific Adenovirus, Chemotherapy and Radiation
Application:
60/192,015 →
Cell-Specific Adenovirus Vectors Comprising an Internal Ribosome Entry Site
Application:
60/192,156 →
Rapid methods and kits for detection and semi-quantitation of anti-adenovirus antibody
Application:
60/214,768 →
Metastatic colon cancer specific promoter and uses thereof
Application:
60/397,859 →
Cell-specific adenovirus vector comprising EBV-specific promoter
Application:
60/423,203 →
System for regulated expression of oncolytic virus
Application:
60/450,232 →
Related Assignments
(2)
Other recorded transfers of the patents in this record — the chain of ownership.